Dr Reddy's Lab’s average revenue will potentially increase 12 per cent Y-o-Y to Rs 7,734 crore as against Rs 6,902 crore in ...

AM(IST)on Thursday in an upbeat market. Mankind Pharma Ltd.(up 4.03 per cent), Gland Pharma Ltd.(up 1.78 per cent), Laurus ...

The Nifty Pharma index closed 0.26 per cent at 21752.00. Benchmark NSE Nifty50 index ended down 26.35 points at 23532.7, ...

Laurus Labs Ltd.(up 1.52 per cent), Glenmark Pharmaceuticals Ltd ... Mankind Pharma Ltd.(down 1.92 per cent), Sanofi India ...

With the rising popularity of telehealth providers offering GLP-1 medications like Ozempic, the terminology can get confusing ...

Motilal Oswal recommended Neutral rating on Dr Reddys Laboratories with a target price of Rs 1390 in its research report ...

Analysts at Zee Business estimate that while Dr Reddy’s may face lower revenues from its US portfolio, Revlimid sales, ...

AM(IST)on Friday in a weak market. Granules India Ltd.(up 1.74 per cent), Laurus Labs Ltd.(up 1.55 per cent), Glenmark ...

Boys who received it as part of a Phase 3 clinical trial produced significant amounts of microdystrophin, a lab-built miniature ... Duchenne experts perplexed. Sanofi proceeded with a plan to ...

Paul Hudson, CEO at Sanofi, said: “Sanofi’s purpose in chasing the miracles of science reaches far beyond our labs […] This capital commitment signals Sanofi’s accelerated ambitions in the ...

SSPC and NIBRT will use the lab to develop processes for advanced therapies ... Eli Lilly Janssen, MSD, Pfizer, and Sanofi on ...

A Palo Alto SaaS company has partnered with the Michael J. Fox Foundation for Parkinson’s Research for AI help in identifying ...